Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-08-01 Sale |
2024-08-05 4:24 pm |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
56,553 | $0 | $0 | 0 (Direct) |
View |
2023-08-14 Sale |
2023-08-15 5:58 pm |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
1,241 | $138.16 | $171,454 | 13,705 (Direct) |
View |
2022-08-05 Sale |
2022-08-09 6:38 pm |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
9,089 | $155.44 | $1,412,797 | 11,871 (Direct) |
View |
2021-12-06 Purchase |
2021-12-08 4:16 pm |
Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO |
100,000 | $2.23 | $223,000 | 1,355,873 (Indirect Direct) |
View |
2021-08-06 Sale |
2021-08-10 5:38 pm |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
1,306 | $147.96 | $193,236 | 10,399 (Direct) |
View |
2020-08-07 Sale |
2020-08-10 4:50 pm |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
931 | $125.87 | $117,186 | 16,224 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-03 Exercise |
2025-01-06 4:22 pm |
N/A N/A |
Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director |
50,000 | $3.78 | 162,145 (Direct) |
View |
2025-01-03 Exercise |
2025-01-06 4:22 pm |
N/A N/A |
Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director |
25,000 | $3.47 | 162,145 (Direct) |
View |
2025-01-03 Exercise |
2025-01-06 4:22 pm |
2021-03-12 2030-03-12 |
Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director |
102,400 | $0 | 162,145 (Direct) |
View |
2025-01-03 Exercise |
2025-01-06 4:22 pm |
N/A N/A |
Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director |
27,400 | $3.58 | 162,145 (Direct) |
View |
2025-01-03 Option Award |
2025-01-06 4:20 pm |
N/A 2035-01-02 |
Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director |
25,000 | $0 | 25,000 (Direct) |
View |
2024-08-02 Option Award |
2024-08-06 6:41 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
3,731 | $0 | 15,952 (Direct) |
View |
2024-08-06 Tax Withholding |
2024-08-06 6:41 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
1,484 | $111.35 | 15,952 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
10,461 | $0 | 56,553 (Direct) |
View |
2024-02-13 Option Award |
2024-02-15 4:15 pm |
N/A 2034-02-12 |
Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director |
30,000 | $0 | 164,555 (Direct) |
View |
2023-08-11 Option Award |
2023-08-15 5:58 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
3,075 | $0 | 13,705 (Direct) |
View |
2023-06-07 Option Award |
2023-06-09 4:15 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
17,062 | $0 | 59,872 (Direct) |
View |
2023-03-03 Option Award |
2023-03-03 4:10 pm |
N/A 2033-02-19 |
Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director |
25,000 | $0 | 134,555 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 4:17 pm |
N/A 2033-01-02 |
Aptinyx Inc. | APTX | RIEDEL NORBERT G EXECUTIVE CHAIRMAN OF THE BOD |
420,000 | $0 | 420,000 (Direct) |
View |
2022-08-05 Exercise |
2022-08-09 6:38 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
8,000 | $55.28 | 11,871 (Direct) |
View |
2022-08-05 Option Award |
2022-08-09 6:38 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
2,561 | $0 | 11,871 (Direct) |
View |
2022-08-05 Exercise |
2022-08-09 6:38 pm |
N/A 2023-05-08 |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
8,000 | $0 | 11,871 (Direct) |
View |
2022-06-14 Option Award |
2022-06-16 4:49 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
23,459 | $0 | 23,459 (Direct) |
View |
2022-02-07 Option Award |
2022-02-28 4:34 pm |
N/A 2032-02-07 |
Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director |
50,000 | $0 | 109,555 (Direct) |
View |
2022-01-04 Exercise |
2022-01-06 4:31 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
14,270 | $0 | 42,810 (Direct) |
View |
2021-12-02 Option Award |
2021-12-07 4:16 pm |
N/A 2031-12-01 |
Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO |
475,000 | $0 | 475,000 (Direct) |
View |
2021-07-29 Option Award |
2021-08-02 6:25 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
2,246 | $0 | 11,705 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 8:14 pm |
N/A 2031-06-10 |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
58,003 | $0 | 58,003 (Direct) |
View |
2021-05-17 Exercise(A) |
2021-05-20 5:53 pm |
N/A N/A |
Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO |
380,000 | $0 | 1,255,873 (Direct) |
View |
2021-05-17 Tax Withholding(A) |
2021-05-20 5:53 pm |
N/A N/A |
Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO |
127,274 | $2.53 | 1,255,873 (Direct) |
View |
2021-05-17 Exercise |
2021-05-19 6:46 pm |
N/A N/A |
Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO |
380,000 | $0 | 615,265 (Direct) |
View |
2021-05-17 Tax Withholding |
2021-05-19 6:46 pm |
N/A N/A |
Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO |
127,274 | $2.53 | 615,265 (Direct) |
View |
2021-05-03 Option Award |
2021-05-05 4:15 pm |
N/A 2031-05-03 |
Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director |
19,655 | $0 | 59,555 (Direct) |
View |
2021-02-24 Option Award |
2021-02-26 7:34 pm |
N/A 2031-02-23 |
Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO |
733,300 | $0 | 733,300 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 4:26 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
14,270 | $0 | 42,810 (Direct) |
View |
Ownership |
2020-10-30 7:51 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
0 | $0 | 42,810 (Direct) |
View |
2020-08-06 Option Award |
2020-08-10 4:50 pm |
N/A 2030-08-05 |
Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director |
9,470 | $0 | 16,224 (Direct) |
View |